Is hospital volume of percutaneous radiofrequency ablation closely associated with treatment outcomes for patients with hepatocellular carcinoma?
Patients who received first-line RFA for HCC in high-volume hospitals demonstrated better survival outcomes.
Both patients with benign diseases and colorectal cancer are included. Furthermore, no clear guidelines on whether to perform a reoperation were available.